Struggling Slavia face Arsenal as grim record looms
Hosting Arsenal in the Champions League on Wednesday, Slavia Prague are facing the mammoth task of ending a drawn-out winless streak in the competition...
Iran warns new war could last longer after Trump threatens strikes
Iran warned on Sunday that any renewed war with the United States could last longer than the previous round of fighting, after President Donald Trump said he still had...
Three things we learned from the United States Grand Prix
Kimi Antonelli stands at the threshold of Formula One's hall of fame, needing just two more points to become the sport's youngest champion and...
Trump blasts Norway over Nobel Peace Prize snub
US President Donald Trump attacked Norway during a campaign rally, calling it a "shithouse country," and said that Norwegian immigrants were not welcome in the United States because its Nobel Committee...
US singer Chris Brown avoids jail over London nightclub brawl
American singer Chris Brown avoided jail when sentenced by a UK court Monday after pleading guilty to a public order offence during a 2023...
10/26/2026 14:00
Even Realities Brings Classic Tortoiseshell Design to Smart Glasses with New Even G2 Brown 2
The new brown colorway pairs traditional eyewear craftsmanship with display-first technology, alongside Even G2 Clip (Polarized) and Even G2 Chain Even Realities, the company behind camera-free, display-first smart glasses, today introduced Brown 2, a new tortoiseshell-inspired colorway for Even G2, alongside two accessories: Even G2 Clip (Polarized) and the Even G2 Chain. Designed to bring the warmth and character of traditional tortoiseshell eyewear to smart glasses, Brown 2 features a newly d...
10/26/2026 13:45
Incyte Highlights New Data Advancing its Gastrointestinal Cancer Portfolio at ESMO 2026
INCB161734 (KRAS G12D inhibitor) and INCA33890 1 (TGFβR2×PD-1 bispecific antibody) data reinforce ongoing and planned registrational trials, including DAWN-303 in pancreatic ductal adenocarcinoma (PDAC) and NEXERA-303 in colorectal cancer (CRC), respectively New data evaluating INCB161734 in CRC highlight its clinical activity across KRAS G12D-mutated tumor types and support initiation of a Phase 3 study in second-line CRC planned for 2027 INCB161734 and INCA33890 demonstrated manageable safety...